Related Experiment Video
Updated: Sep 20, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Deep Learning-Based Multimodal Feature Interaction-Guided Fusion: Enhancing the Evaluation of EGFR in Advanced Lung
Junhui Xu1, Bao Feng2, Xiangmeng Chen3
1School of Automation, Guangxi University of Science and Technology, Liuzhou, Guangxi, China (J.X., Z.Y., X.D.).
Rationale And Objectives:
The aim of this study is to develop a deep learning-based multimodal feature interaction-guided fusion (DL-MFIF) framework that integrates macroscopic information from computed tomography (CT) images with microscopic information from whole-slide images (WSIs) to predict the epidermal growth factor receptor (EGFR) mutations of primary lung adenocarcinoma in patients with advanced-stage disease.
Materials And Methods:
Data from 396 patients with lung adenocarcinoma across two medical institutions were analyzed. The data from 243 cases were divided into a training set (n=145) and an internal validation set (n=98) in a 6:4 ratio, and data from an additional 153 cases from another medical institution were included as an external validation set. All cases included CT scan images and WSIs. To integrate multimodal information, we developed the DL-MFIF framework, which leverages deep learning techniques to capture the interactions between radiomic macrofeatures derived from CT images and microfeatures obtained from WSIs.
Results:
Compared to other classification models, the DL-MFIF model achieved significantly higher area under the curve (AUC) values. Specifically, the model outperformed others on both the internal validation set (AUC=0.856, accuracy=0.750) and the external validation set (AUC=0.817, accuracy=0.708). Decision curve analysis (DCA) demonstrated that the model provided superior net benefits(range 0.15-0.87). Delong's test for external validation confirmed the statistical significance of the results (P<0.05).
Conclusion:
The DL-MFIF model demonstrated excellent performance in evaluating and distinguishing the EGFR in patients with advanced lung adenocarcinoma. This model effectively aids radiologists in accurately classifying EGFR mutations in patients with primary lung adenocarcinoma, thereby improving treatment outcomes for this population.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016